Francesca Pellizzari Tregno

The glutathione S-transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol overcomes the MDR1-P-glycoprotein and MRP1-mediated multidrug resistance in acute myeloid leukemia cells

A. Caccuri, S. Pezzola, M. Dupuis, 2009, Cancer Chemotherapy and Pharmacology.

Glutathione transferases and development of new principles to overcome drug resistance.

A. Caccuri, G. Federici, F. Valentino, 2010, Archives of biochemistry and biophysics.

Glutathione S‐transferase P1‐1 as a target for mesothelioma treatment

A. Caccuri, G. Federici, C. Palumbo, 2013, Cancer science.

In vitro and in vivo efficacy of 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) on human melanoma.

G. Filomeni, A. Caccuri, G. Federici, 2009, European journal of cancer.